Free Trial
→ Is $24 trillion about to move? (From The Oxford Club) (Ad)tc pixel Free PHR Stock Alerts

Phreesia (PHR) Financials

Phreesia logo
$9.51 -0.06 (-0.63%)
As of 12:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Phreesia

Annual Income Statements for Phreesia

This table shows Phreesia's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -38 -45 -91 -27 -118 -176 -137 -59
Consolidated Net Income / (Loss)		 -18 -15 -20 -27 -118 -176 -137 -59
Net Income / (Loss) Continuing Operations		 -18 -15 -20 -27 -118 -176 -137 -59
Total Pre-Tax Income 		-18 -15 -22 -27 -118 -176 -135 -56
Total Operating Income		 -15 -9.49 -15 -26 -117 -177 -136 -58
Total Gross Profit		 50 63 80 96 132 172 232 285
Total Revenue		 80 100 125 149 213 281 356 420
Operating Revenue		 80 100 125 149 213 281 356 420
Total Cost of Revenue		 30 37 45 52 81 109 124 135
Operating Cost of Revenue		 30 37 45 52 81 109 124 135
Total Operating Expenses		 65 72 95 122 249 348 369 343
Selling, General & Admin Expense		 19 20 30 40 69 80 80 77
Marketing Expense		 25 26 32 43 106 151 147 121
Research & Development Expense		 11 14 19 23 52 91 112 117
Depreciation Expense		 6.83 7.55 8.75 9.77 15 18 18 14
Amortization Expense		 2.81 4.04 5.17 6.14 6.32 7.32 12 14
Total Other Income / (Expense), net		 -3.64 -5.57 -6.78 -1.57 -1.16 0.89 1.14 2.29
Interest Expense		 3.64 3.50 2.45 1.57 1.08 0.00 1.12 0.00
Interest & Investment Income		 - - - - - 1.06 2.21 0.33
Other Income / (Expense), net		 0.00 -2.07 -4.33 0.00 -0.08 -0.18 0.04 1.96
Income Tax Expense		 0.00 0.00 -1.78 0.05 0.18 0.48 1.54 2.72
Basic Earnings per Share		 ($24.81) ($24.53) ($4.50) ($0.69) ($2.37) ($3.36) ($2.51) ($1.02)
Weighted Average Basic Shares Outstanding		 1.54M 1.84M 20.30M 39.52M 49.89M 52.44M 54.56M 57.59M
Diluted Earnings per Share		 ($24.81) ($24.53) ($4.50) ($0.69) ($2.37) ($3.36) ($2.51) ($1.02)
Weighted Average Diluted Shares Outstanding		 1.54M 1.84M 20.30M 39.52M 49.89M 52.44M 54.56M 57.59M
Weighted Average Basic & Diluted Shares Outstanding		 1.54M 1.84M 20.30M 39.52M 51.95M 53.36M 56.39M 58.77M

Quarterly Income Statements for Phreesia

This table shows Phreesia's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -38 -37 -32 -31 -20 -18 -14 -6.39 -3.91 0.65 4.27
Consolidated Net Income / (Loss)		 -38 -37 -32 -31 -20 -18 -14 -6.39 -3.91 0.65 4.27
Net Income / (Loss) Continuing Operations		 -38 -37 -32 -31 -20 -18 -14 -6.39 -3.91 0.65 4.27
Total Pre-Tax Income 		-37 -36 -32 -30 -19 -17 -14 -5.38 -3.18 -0.56 5.13
Total Operating Income		 -38 -37 -32 -30 -19 -17 -14 -7.61 -3.29 -1.51 3.74
Total Gross Profit		 53 56 61 63 67 69 72 76 78 80 82
Total Revenue		 84 86 92 95 101 102 107 110 116 117 120
Operating Revenue		 84 86 92 95 101 102 107 110 116 117 120
Total Cost of Revenue		 31 30 31 32 34 33 35 34 38 38 38
Operating Cost of Revenue		 31 30 31 32 34 33 35 34 38 38 38
Total Operating Expenses		 91 92 93 93 87 87 86 84 81 81 79
Selling, General & Admin Expense		 20 21 20 19 19 19 20 18 16 19 17
Marketing Expense		 37 37 36 36 32 30 30 29 26 25 24
Research & Development Expense		 26 27 29 30 29 30 29 30 32 29 29
Depreciation Expense		 4.50 4.24 4.48 4.35 3.52 3.92 3.57 3.17 2.99 3.28 3.20
Amortization Expense		 2.49 2.54 2.98 3.90 3.15 3.38 3.52 3.65 3.89 4.13 4.28
Total Other Income / (Expense), net		 0.68 0.84 0.48 -0.85 0.21 -0.04 -0.12 2.24 0.11 0.94 1.39
Interest & Investment Income		 0.72 0.79 0.52 0.18 0.24 0.05 0.03 0.02 -0.23 0.61 0.38
Other Income / (Expense), net		 -0.04 0.05 -0.05 0.08 -0.03 -0.09 -0.14 2.22 0.34 0.34 1.01
Income Tax Expense		 0.31 0.65 0.37 0.22 0.51 0.75 0.44 1.01 0.74 -1.22 0.85
Basic Earnings per Share		 ($0.70) ($0.68) ($0.58) ($0.55) ($0.35) ($0.31) ($0.25) ($0.11) ($0.07) $0.01 $0.07
Weighted Average Basic Shares Outstanding		 53.35M 53.79M 55.25M 54.56M 56.67M 57.50M 57.89M 57.59M 58.92M 59.59M 60.01M
Diluted Earnings per Share		 ($0.70) ($0.68) ($0.58) ($0.55) ($0.35) ($0.31) ($0.25) ($0.11) ($0.07) $0.01 $0.07
Weighted Average Diluted Shares Outstanding		 53.35M 53.79M 55.25M 54.56M 56.67M 57.50M 57.89M 57.59M 58.92M 61.69M 61.56M
Weighted Average Basic & Diluted Shares Outstanding		 53.66M 55.21M 55.63M 56.39M 57.40M 57.77M 58.12M 58.77M 59.50M 59.91M 60.29M

Annual Cash Flow Statements for Phreesia

This table details how cash moves in and out of Phreesia's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Net Change in Cash & Equivalents		 8.18 -8.96 89 128 95 -137 -89 -3.30
Net Cash From Operating Activities		 -11 -2.13 0.83 2.89 -75 -90 -32 32
Net Cash From Continuing Operating Activities		 -11 -2.13 0.83 2.89 -75 -90 -32 32
Net Income / (Loss) Continuing Operations		 -18 -15 -20 -27 -118 -176 -137 -59
Consolidated Net Income / (Loss)		 -18 -15 -20 -27 -118 -176 -137 -59
Depreciation Expense		 9.64 12 14 16 21 25 29 28
Amortization Expense		 2.29 2.44 2.42 2.41 2.50 2.01 1.38 2.05
Non-Cash Adjustments To Reconcile Net Income		 -0.37 1.59 11 16 38 62 75 67
Changes in Operating Assets and Liabilities, net		 -4.51 -2.69 -6.53 -4.16 -18 -3.43 -1.41 -6.28
Net Cash From Investing Activities		 -12 -11 -12 -25 -65 -26 -40 -24
Net Cash From Continuing Investing Activities		 -12 -11 -12 -25 -65 -26 -40 -24
Purchase of Property, Plant & Equipment		 -12 -9.83 -12 -19 -31 -26 -25 -24
Acquisitions		 0.00 -1.19 - -6.51 -34 0.00 -15 0.00
Net Cash From Financing Activities		 31 4.19 100 151 235 -21 -17 -11
Net Cash From Continuing Financing Activities		 31 4.19 100 151 235 -21 -17 -11
Repayment of Debt		 -24 -8.30 -39 -23 -1.16 -0.61 -2.68 -1.35
Issuance of Debt		 22 15 30 - 0.00 0.00 1.69 0.00
Issuance of Common Equity		 0.00 0.00 131 175 248 3.32 3.21 2.92
Other Financing Activities, net		 0.15 -2.11 -0.09 -1.20 -12 -24 -19 -13
Effect of Exchange Rate Changes		 - - - - - 0.00 0.00 -0.11
Cash Interest Paid		 2.80 2.80 2.31 1.47 0.80 0.76 1.31 2.19
Cash Income Taxes Paid		 - 0.00 0.00 0.06 0.05 0.04 0.04 3.07

Quarterly Cash Flow Statements for Phreesia

This table details how cash moves in and out of Phreesia's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025
Net Change in Cash & Equivalents		 -27 -22 -24 -16 -7.99 2.27 -0.06 2.48 6.65 7.40 8.11
Net Cash From Operating Activities		 -14 -9.33 -6.31 -3.08 -0.72 11 5.79 16 15 15 15
Net Cash From Continuing Operating Activities		 -14 -9.33 -6.31 -3.08 -0.72 11 5.79 16 15 15 15
Net Income / (Loss) Continuing Operations		 -38 -37 -32 -31 -20 -18 -14 -6.39 -3.91 0.65 4.27
Consolidated Net Income / (Loss)		 -38 -37 -32 -31 -20 -18 -14 -6.39 -3.91 0.65 4.27
Depreciation Expense		 6.99 6.78 7.46 8.25 6.67 7.30 7.09 6.82 6.88 7.41 7.48
Amortization Expense		 0.43 0.36 0.32 0.27 0.25 0.24 1.38 0.17 0.17 0.30 0.17
Non-Cash Adjustments To Reconcile Net Income		 18 19 19 20 17 17 18 16 18 17 16
Changes in Operating Assets and Liabilities, net		 -1.33 1.30 -0.84 -0.54 -5.28 4.98 -6.01 0.03 -6.16 -10 -13
Net Cash From Investing Activities		 -6.08 -9.72 -16 -8.16 -5.45 -7.40 -4.18 -7.06 -7.39 -5.20 -6.67
Net Cash From Continuing Investing Activities		 -6.08 -9.72 -16 -8.16 -5.45 -7.40 -4.18 -7.06 -7.39 -5.20 -6.67
Purchase of Property, Plant & Equipment		 -6.08 -5.84 -5.31 -7.86 -5.45 -7.40 -4.18 -7.06 -7.39 -5.20 -6.67
Net Cash From Financing Activities		 -7.18 -3.04 -2.28 -4.61 -1.83 -1.38 -1.65 -6.63 -0.84 -2.15 -0.67
Net Cash From Continuing Financing Activities		 -7.18 -3.04 -2.28 -4.61 -1.83 -1.38 -1.65 -6.63 -0.84 -2.15 -0.67
Repayment of Debt		 0.00 -0.30 -0.27 -2.11 -0.44 -0.30 -0.30 -0.31 -0.36 -0.33 -0.35
Issuance of Common Equity		 0.97 0.90 0.92 0.43 0.91 0.69 0.84 0.48 0.77 0.58 0.63
Other Financing Activities, net		 -8.15 -5.33 -2.93 -2.93 -2.30 -1.78 -2.19 -6.79 -1.25 -2.40 -0.95
Effect of Exchange Rate Changes		 0.00 - - - -0.00 -0.01 -0.01 -0.09 0.03 -0.09 -0.03
Cash Interest Paid		 0.06 0.30 0.30 0.66 0.48 0.38 0.60 0.74 0.32 0.33 0.24
Cash Income Taxes Paid		 0.04 0.01 -0.01 -0.01 1.59 0.42 0.55 0.51 0.55 0.76 0.33

Annual Balance Sheets for Phreesia

This table presents Phreesia's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Total Assets		 59 159 327 494 370 370 388
Total Current Assets		 33 132 272 386 262 196 203
Cash & Equivalents		 1.54 90 219 314 177 88 84
Accounts Receivable		 16 22 29 40 51 65 74
Prepaid Expenses		 3.81 5.16 7.25 11 11 14 16
Other Current Assets		 12 14 17 21 24 29 30
Plant, Property, & Equipment, net		 14 14 0.00 0.00 22 17 24
Total Noncurrent Assets		 12 13 54 108 86 158 161
Goodwill		 0.25 0.25 8.31 34 34 76 76
Intangible Assets		 9.25 9.93 13 30 47 78 81
Noncurrent Deferred & Refundable Income Taxes		 0.00 0.78 0.66 0.52 0.08 - 0.00
Other Noncurrent Operating Assets		 2.23 1.77 32 44 5.58 4.13 4.73
Total Liabilities & Shareholders' Equity		 59 159 327 494 370 370 388
Total Liabilities		 64 57 63 77 82 119 124
Total Current Liabilities		 28 35 55 68 79 110 114
Short-Term Debt		 1.97 2.32 4.86 5.82 5.17 6.06 8.04
Accounts Payable		 3.75 6.02 4.39 5.12 11 8.48 5.62
Accrued Expenses		 5.51 9.24 18 20 22 37 37
Current Deferred Revenue		 6.49 5.40 11 16 18 24 33
Other Current Liabilities		 10 12 17 21 24 34 30
Total Noncurrent Liabilities		 36 22 8.37 8.76 3.20 8.76 9.58
Long-Term Debt		 28 22 6.47 7.42 2.73 5.40 8.15
Noncurrent Deferred Revenue		 - - - 0.07 0.13 0.10 0.12
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - 0.00 0.27 0.48
Other Noncurrent Operating Liabilities		 5.50 0.00 1.90 1.28 0.35 2.99 0.83
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -211 102 263 417 288 251 265
Total Preferred & Common Equity		 -211 102 263 417 288 251 265
Preferred Stock		 - - - - 0.00 0.00 0.00
Total Common Equity		 -211 102 263 417 288 251 265
Common Stock		 0.02 387 580 861 927 1,040 1,112
Retained Earnings		 -211 -284 -312 -430 -606 -743 -801
Treasury Stock		 0.00 -0.40 -4.97 -14 -34 -46 -46
Accumulated Other Comprehensive Income / (Loss)		 - - - - - 0.00 -0.05

Quarterly Balance Sheets for Phreesia

This table presents Phreesia's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 7/31/2022 10/31/2022 4/30/2023 7/31/2023 10/31/2023 4/30/2024 7/31/2024 10/31/2024 4/30/2025 7/31/2025 10/31/2025
Total Assets		 426 397 354 340 375 372 362 376 400 409 423
Total Current Assets		 316 287 240 219 199 191 181 190 215 223 241
Cash & Equivalents		 241 210 150 128 103 80 82 82 91 98 106
Accounts Receivable		 47 44 53 54 57 66 61 71 75 77 88
Prepaid Expenses		 7.72 11 10 12 14 14 12 11 16 18 20
Other Current Assets		 21 22 27 26 25 31 26 25 33 29 26
Plant, Property, & Equipment, net		 0.00 0.00 0.00 0.00 20 22 21 26 23 23 21
Total Noncurrent Assets		 109 110 114 121 156 159 160 160 161 163 161
Goodwill		 34 34 34 41 75 76 76 76 76 76 76
Intangible Assets		 40 44 49 54 77 79 80 80 81 80 80
Noncurrent Deferred & Refundable Income Taxes		 0.08 0.00 0.00 0.00 0.00 - - - - 1.64 1.64
Other Noncurrent Operating Assets		 36 33 31 26 3.28 4.23 4.86 3.98 4.85 5.45 4.35
Total Liabilities & Shareholders' Equity		 426 397 354 340 375 372 362 376 400 409 423
Total Liabilities		 78 77 90 93 110 119 111 121 118 111 103
Total Current Liabilities		 72 73 83 85 98 108 102 109 111 105 99
Short-Term Debt		 5.72 5.48 6.98 7.11 6.75 7.75 7.16 8.87 8.35 7.10 6.20
Accounts Payable		 10 11 7.60 7.95 11 6.68 6.98 16 3.20 6.53 6.22
Accrued Expenses		 18 20 23 28 28 33 33 29 34 35 31
Current Deferred Revenue		 17 14 18 16 22 24 21 22 31 27 30
Other Current Liabilities		 21 22 27 26 30 37 34 33 34 30 26
Total Noncurrent Liabilities		 5.58 4.23 7.26 8.55 12 11 8.90 12 7.49 5.51 4.36
Long-Term Debt		 4.93 3.77 6.69 8.06 6.85 8.69 7.30 10 6.16 4.58 3.35
Noncurrent Deferred Revenue		 0.01 0.00 0.18 0.10 0.10 0.08 0.06 0.20 0.11 0.08 0.15
Noncurrent Deferred & Payable Income Tax Liabilities		 - - 0.14 0.18 0.22 0.33 0.39 0.45 0.57 0.63 0.68
Other Noncurrent Operating Liabilities		 0.63 0.46 0.26 0.22 4.46 1.96 1.15 0.97 0.65 0.22 0.17
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 348 320 264 247 265 253 251 255 282 298 320
Total Preferred & Common Equity		 348 320 264 247 265 253 251 255 282 298 320
Preferred Stock		 - - - - - 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 348 320 264 247 265 253 251 255 282 298 320
Common Stock		 897 912 948 972 1,022 1,061 1,078 1,095 1,133 1,148 1,167
Retained Earnings		 -528 -568 -644 -680 -712 -763 -781 -795 -805 -805 -800
Treasury Stock		 -20 -24 -41 -44 -46 -46 -46 -46 -46 -46 -46
Accumulated Other Comprehensive Income / (Loss)		 - - - - - 0.00 -0.00 -0.01 0.38 0.11 -0.36

Annual Metrics And Ratios for Phreesia

This table displays calculated financial ratios and metrics derived from Phreesia's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025
Growth Metrics		 - - - - - - - -
Revenue Growth		 0.00% 25.12% 24.92% 19.15% 43.42% 31.74% 26.84% 17.83%
EBITDA Growth		 0.00% 194.53% -232.71% -123.89% -1,166.93% -60.50% 29.34% 75.18%
EBIT Growth		 0.00% 20.55% -69.81% -30.78% -355.38% -51.18% 22.80% 58.85%
NOPAT Growth		 0.00% 34.76% -61.13% -67.81% -355.05% -51.14% 22.70% 57.43%
Net Income Growth		 0.00% 17.21% -34.73% -34.49% -332.95% -49.07% 22.29% 57.24%
EPS Growth		 0.00% 1.13% 81.66% 84.67% -243.48% -41.77% 25.30% 59.36%
Operating Cash Flow Growth		 0.00% 80.88% 138.78% 249.88% -2,685.12% -20.63% 64.07% 200.01%
Free Cash Flow Firm Growth		 0.00% 0.00% 39.63% -93.40% -271.26% 11.72% -20.63% 59.14%
Invested Capital Growth		 0.00% 0.00% 34.86% 57.73% 108.94% 1.99% 47.34% 12.20%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 6.44% 8.23% 7.08% 5.45% 3.62%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% -78.48% -63.51% 4.92% 9.77% 46.28%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% -13.72% -49.12% 3.69% 7.01% 30.03%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% -16.36% -48.85% 3.71% 6.98% 27.44%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% -19.37% -48.06% 4.57% 5.11% 29.30%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 6.15% 6.34% 30.14%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 119.45% 3,221.84% -128.79% 19.68% 28.37% 148.19%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% -84.09% 30.48% 3.58% 15.24%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 24.91% 73.54% -0.81% 0.32% 2.48%
Profitability Metrics		 - - - - - - - -
Gross Margin		 62.71% 62.96% 64.16% 64.77% 61.83% 61.10% 65.19% 67.86%
EBITDA Margin		 -3.28% 2.48% -2.63% -4.94% -43.66% -53.19% -29.63% -6.24%
Operating Margin		 -18.23% -9.50% -12.26% -17.27% -54.78% -62.85% -38.30% -13.84%
EBIT Margin		 -18.22% -11.57% -15.73% -17.27% -54.82% -62.91% -38.29% -13.37%
Profit (Net Income) Margin		 -22.79% -15.08% -16.26% -18.36% -55.41% -62.71% -38.42% -13.94%
Tax Burden Percent		 100.00% 100.00% 91.94% 100.18% 100.15% 100.28% 101.14% 104.87%
Interest Burden Percent		 125.04% 130.31% 112.46% 106.13% 100.93% 99.40% 99.20% 99.41%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% -50.62% -34.73% -39.38% -94.77% -104.85% -64.90% -21.85%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -105.37% 18.96% -32.57% -80.44% -82.45% -31.12% 2.93%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 722.43% -6.95% 24.43% 60.05% 54.88% 14.13% -0.82%
Return on Equity (ROE)		 0.00% 671.81% -41.68% -14.95% -34.72% -49.96% -50.77% -22.67%
Cash Return on Invested Capital (CROIC)		 0.00% -250.62% -64.42% -84.18% -165.29% -106.82% -103.18% -33.35%
Operating Return on Assets (OROA)		 0.00% -19.50% -18.01% -10.58% -28.47% -40.88% -36.86% -14.80%
Return on Assets (ROA)		 0.00% -25.42% -18.62% -11.24% -28.78% -40.75% -36.98% -15.43%
Return on Common Equity (ROCE)		 0.00% 31,608.97% 46.70% -14.95% -34.72% -49.96% -50.77% -22.67%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 7.14% -19.92% -10.37% -28.32% -61.20% -54.44% -22.10%
Net Operating Profit after Tax (NOPAT)		 -10 -6.65 -11 -18 -82 -124 -96 -41
NOPAT Margin		 -12.76% -6.65% -8.58% -12.09% -38.35% -44.00% -26.81% -9.69%
Net Nonoperating Expense Percent (NNEP)		 0.00% 54.75% -53.68% -6.81% -14.33% -22.40% -33.78% -24.79%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - -41.79% -36.34% -14.47%
Cost of Revenue to Revenue		 37.29% 37.04% 35.84% 35.23% 38.17% 38.90% 34.81% 32.14%
SG&A Expenses to Revenue		 23.60% 20.10% 24.41% 27.21% 32.21% 28.62% 22.43% 18.25%
R&D to Revenue		 14.25% 14.36% 14.92% 15.22% 24.51% 32.48% 31.53% 27.96%
Operating Expenses to Revenue		 80.94% 72.47% 76.42% 82.03% 116.62% 123.95% 103.50% 81.70%
Earnings before Interest and Taxes (EBIT)		 -15 -12 -20 -26 -117 -177 -136 -56
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -2.62 2.47 -3.28 -7.35 -93 -149 -106 -26
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 10.92 10.95 3.83 6.87 5.64 6.25
Price to Tangible Book Value (P/TBV)		 0.00 0.00 12.13 11.92 4.52 9.53 14.49 15.31
Price to Revenue (P/Rev)		 2.09 1.67 8.91 19.39 7.50 7.04 3.98 3.94
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 15.40 29.54 47.90 11.12 15.20 7.65 8.06
Enterprise Value to Revenue (EV/Rev)		 0.00 4.05 8.38 18.00 6.09 6.44 3.77 3.78
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 163.53 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 1,266.33 925.93 0.00 0.00 0.00 48.99
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.00 -7.20 0.23 0.04 0.03 0.03 0.05 0.06
Long-Term Debt to Equity		 0.00 -6.76 0.21 0.02 0.02 0.01 0.02 0.03
Financial Leverage		 0.00 -6.86 -0.37 -0.75 -0.75 -0.67 -0.45 -0.28
Leverage Ratio		 0.00 -13.22 2.24 1.33 1.21 1.23 1.37 1.47
Compound Leverage Factor		 0.00 -17.22 2.52 1.41 1.22 1.22 1.36 1.46
Debt to Total Capital		 0.00% 116.13% 18.98% 4.13% 3.08% 2.67% 4.36% 5.76%
Short-Term Debt to Total Capital		 0.00% 7.07% 1.85% 1.77% 1.35% 1.75% 2.30% 2.86%
Long-Term Debt to Total Capital		 0.00% 109.06% 17.13% 2.36% 1.72% 0.92% 2.05% 2.90%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 742.74% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% -758.87% 81.02% 95.87% 96.92% 97.33% 95.64% 94.24%
Debt to EBITDA		 0.00 13.06 -7.27 -1.54 -0.14 -0.05 -0.11 -0.62
Net Debt to EBITDA		 0.00 12.43 20.25 28.23 3.23 1.13 0.72 2.60
Long-Term Debt to EBITDA		 0.00 12.26 -6.56 -0.88 -0.08 -0.02 -0.05 -0.31
Debt to NOPAT		 0.00 -4.86 -2.23 -0.63 -0.16 -0.06 -0.12 -0.40
Net Debt to NOPAT		 0.00 -4.63 6.21 11.54 3.68 1.37 0.80 1.67
Long-Term Debt to NOPAT		 0.00 -4.56 -2.01 -0.36 -0.09 -0.02 -0.06 -0.20
Altman Z-Score		 0.00 -2.26 10.33 26.96 11.63 11.91 4.37 6.02
Noncontrolling Interest Sharing Ratio		 0.00% -4,605.04% 212.04% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 0.00 1.19 3.72 4.95 5.65 3.32 1.78 1.78
Quick Ratio		 0.00 0.63 3.18 4.51 5.17 2.89 1.38 1.38
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -33 -20 -38 -143 -126 -152 -62
Operating Cash Flow to CapEx		 -93.12% -21.66% 6.70% 15.56% -242.53% -343.94% -129.01% 134.42%
Free Cash Flow to Firm to Interest Expense		 0.00 -9.39 -8.12 -24.42 -131.57 0.00 -135.86 0.00
Operating Cash Flow to Interest Expense		 -3.06 -0.61 0.34 1.84 -68.92 0.00 -28.96 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -6.34 -3.41 -4.70 -9.97 -97.34 0.00 -51.41 0.00
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.00 1.69 1.14 0.61 0.52 0.65 0.96 1.11
Accounts Receivable Turnover		 0.00 6.21 6.56 5.83 6.15 6.13 6.13 6.06
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 7.03 8.70 0.00 0.00 0.00 18.47 20.70
Accounts Payable Turnover		 0.00 9.87 9.16 10.07 17.12 13.70 12.84 19.14
Days Sales Outstanding (DSO)		 0.00 58.73 55.65 62.64 59.32 59.55 59.55 60.20
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 37.00 39.86 36.25 21.32 26.65 28.43 19.07
Cash Conversion Cycle (CCC)		 0.00 21.74 15.79 26.39 38.00 32.90 31.12 41.13
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 0.00 26 35 56 117 119 175 197
Invested Capital Turnover		 0.00 7.61 4.05 3.26 2.47 2.38 2.42 2.26
Increase / (Decrease) in Invested Capital		 0.00 26 9.16 20 61 2.32 56 21
Enterprise Value (EV)		 0.00 404 1,046 2,676 1,298 1,809 1,342 1,586
Market Capitalization		 167 167 1,112 2,883 1,598 1,977 1,418 1,654
Book Value per Share		 $0.00 ($114.35) $2.84 $5.96 $8.14 $5.46 $4.52 $4.56
Tangible Book Value per Share		 $0.00 ($119.50) $2.55 $5.48 $6.89 $3.93 $1.76 $1.86
Total Capital		 0.00 28 126 275 431 296 263 281
Total Debt		 0.00 32 24 11 13 7.90 11 16
Total Long-Term Debt		 0.00 30 22 6.47 7.42 2.73 5.40 8.15
Net Debt		 0.00 31 -66 -207 -301 -169 -76 -68
Capital Expenditures (CapEx)		 12 9.83 12 19 31 26 25 24
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 5.81 8.19 3.36 9.93 12 4.10 13
Debt-free Net Working Capital (DFNWC)		 0.00 7.35 99 222 324 189 92 97
Net Working Capital (NWC)		 0.00 5.39 96 217 318 183 86 89
Net Nonoperating Expense (NNE)		 8.00 8.42 9.58 9.32 36 53 41 18
Net Nonoperating Obligations (NNO)		 0.00 31 -66 -207 -301 -169 -76 -68
Total Depreciation and Amortization (D&A)		 12 14 16 18 24 27 31 30
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 5.82% 6.57% 2.26% 4.66% 4.23% 1.15% 3.12%
Debt-free Net Working Capital to Revenue		 0.00% 7.36% 78.94% 149.41% 151.82% 67.13% 25.71% 23.18%
Net Working Capital to Revenue		 0.00% 5.39% 77.08% 146.14% 149.09% 65.29% 24.01% 21.26%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($4.50) ($0.69) ($2.37) ($3.36) ($2.51) ($1.02)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 37.52M 44.90M 49.89M 52.44M 54.56M 57.59M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($4.50) ($0.69) ($2.37) ($3.36) ($2.51) ($1.02)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 37.52M 44.90M 49.89M 52.44M 54.56M 57.59M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 ($4.50) ($0.69) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 20.30M 39.52M 51.95M 53.36M 56.39M 58.77M
Normalized Net Operating Profit after Tax (NOPAT)		 -10 -6.65 -11 -18 -82 -124 -96 -41
Normalized NOPAT Margin		 -12.76% -6.65% -8.58% -12.09% -38.35% -44.00% -26.81% -9.69%
Pre Tax Income Margin		 -22.79% -15.08% -17.69% -18.32% -55.33% -62.53% -37.99% -13.29%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 -3.99 -3.30 -8.03 -16.32 -107.84 0.00 -122.03 0.00
NOPAT to Interest Expense		 -2.80 -1.90 -4.38 -11.42 -75.44 0.00 -85.45 0.00
EBIT Less CapEx to Interest Expense		 -7.28 -6.11 -13.07 -28.13 -136.25 0.00 -144.48 0.00
NOPAT Less CapEx to Interest Expense		 -6.08 -4.70 -9.42 -23.23 -103.85 0.00 -107.90 0.00
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% -73.70% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -1.29% -104.33% -1.06% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Phreesia

This table displays calculated financial ratios and metrics derived from Phreesia's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 4/30/2023 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 32.34% 26.47% 25.33% 24.05% 20.72% 18.97% 16.57% 15.45% 14.54% 14.83% 12.67%
EBITDA Growth		 30.93% 25.55% 25.98% 35.27% 58.97% 67.20% 77.31% 107.62% 132.74% 167.02% 324.71%
EBIT Growth		 25.05% 20.29% 19.81% 25.86% 48.74% 53.10% 56.42% 81.71% 84.84% 93.23% 133.92%
NOPAT Growth		 25.09% 20.24% 19.51% 25.71% 48.76% 53.40% 56.80% 74.26% 83.07% 91.25% 132.16%
Net Income Growth		 26.76% 21.30% 20.48% 19.40% 47.45% 51.01% 54.91% 79.15% 80.15% 103.63% 129.65%
EPS Growth		 29.29% 23.60% 23.68% 23.61% 50.00% 54.41% 56.90% 80.00% 80.00% 103.23% 128.00%
Operating Cash Flow Growth		 59.39% 52.98% 69.59% 80.64% 94.72% 218.54% 191.68% 628.14% 2,159.64% 34.12% 167.36%
Free Cash Flow Firm Growth		 69.26% 55.33% 4.17% -155.24% -153.12% -46.55% 65.22% 65.32% 75.60% 53.77% -5.63%
Invested Capital Growth		 2.73% 13.62% 45.69% 47.34% 48.73% 36.79% 9.83% 12.20% 8.53% 14.89% 16.41%
Revenue Q/Q Growth		 9.48% 2.37% 6.74% 3.70% 6.54% 0.89% 4.59% 2.70% 5.70% 1.14% 2.63%
EBITDA Q/Q Growth		 5.78% 2.52% 18.31% 13.73% 40.28% 22.06% 43.50% 128.99% 156.47% 59.52% 89.47%
EBIT Q/Q Growth		 4.63% 2.74% 13.04% 8.09% 34.05% 11.02% 19.19% 61.43% 45.34% 60.29% 505.21%
NOPAT Q/Q Growth		 4.80% 2.50% 13.29% 7.70% 34.34% 11.32% 19.62% 45.01% 56.82% 54.15% 395.38%
Net Income Q/Q Growth		 1.29% 2.04% 13.13% 4.05% 35.65% 8.67% 20.04% 55.63% 38.75% 116.71% 553.06%
EPS Q/Q Growth		 2.78% 2.86% 14.71% 5.17% 36.36% 11.43% 19.35% 56.00% 36.36% 114.29% 600.00%
Operating Cash Flow Q/Q Growth		 14.09% 31.69% 32.38% 51.22% 76.58% 1,634.12% -47.70% 181.00% -8.65% -0.10% 4.26%
Free Cash Flow Firm Q/Q Growth		 0.90% -40.36% -83.97% 0.26% 1.72% 18.74% 56.34% 0.54% 30.87% -54.00% 0.24%
Invested Capital Q/Q Growth		 7.13% 5.49% 29.98% 0.32% 8.13% -2.98% 4.36% 2.48% 4.60% 2.71% 5.73%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 63.03% 64.70% 66.23% 66.56% 66.39% 67.87% 67.66% 69.40% 67.17% 67.90% 68.40%
EBITDA Margin		 -36.41% -34.67% -26.53% -22.08% -12.37% -9.56% -5.16% 1.46% 3.54% 5.58% 10.30%
Operating Margin		 -45.20% -43.06% -34.98% -31.13% -19.19% -16.87% -12.96% -6.94% -2.84% -1.29% 3.11%
EBIT Margin		 -45.25% -43.00% -35.03% -31.05% -19.22% -16.95% -13.10% -4.92% -2.54% -1.00% 3.94%
Profit (Net Income) Margin		 -44.76% -42.84% -34.86% -32.26% -19.48% -17.64% -13.49% -5.83% -3.38% 0.56% 3.55%
Tax Burden Percent		 100.82% 101.79% 101.18% 100.71% 102.65% 104.34% 103.17% 118.86% 123.12% -116.16% 83.34%
Interest Burden Percent		 98.11% 97.87% 98.37% 103.17% 98.77% 99.73% 99.81% 99.65% 107.80% 48.08% 108.01%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.66%
Return on Invested Capital (ROIC)		 -75.80% -76.12% -56.12% -52.75% -31.65% -28.91% -20.04% -10.96% -4.36% -2.05% 5.77%
ROIC Less NNEP Spread (ROIC-NNEP)		 -70.20% -69.76% -49.56% -44.63% -25.49% -22.28% -13.85% -9.49% -2.05% -4.27% 4.32%
Return on Net Nonoperating Assets (RNNOA)		 42.81% 40.13% 24.58% 20.26% 9.83% 8.04% 4.07% 2.65% 0.53% 1.20% -1.20%
Return on Equity (ROE)		 -32.99% -35.99% -31.54% -32.48% -21.81% -20.87% -15.98% -8.31% -3.83% -0.85% 4.57%
Cash Return on Invested Capital (CROIC)		 -93.85% -98.27% -106.86% -103.18% -91.27% -74.27% -39.92% -33.35% -23.04% -23.15% -18.08%
Operating Return on Assets (OROA)		 -33.56% -35.83% -30.66% -29.88% -19.78% -18.81% -14.14% -5.44% -2.86% -1.17% 4.57%
Return on Assets (ROA)		 -33.19% -35.70% -30.52% -31.05% -20.06% -19.58% -14.56% -6.45% -3.80% 0.65% 4.11%
Return on Common Equity (ROCE)		 -32.99% -35.99% -31.54% -32.48% -21.81% -20.87% -15.98% -8.31% -3.83% -0.85% 4.57%
Return on Equity Simple (ROE_SIMPLE)		 -61.62% -61.73% -54.52% 0.00% -47.11% -39.92% -32.52% 0.00% -15.14% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -27 -26 -22 -21 -14 -12 -9.69 -5.33 -2.30 -1.05 3.12
NOPAT Margin		 -31.64% -30.14% -24.48% -21.79% -13.43% -11.81% -9.07% -4.86% -1.98% -0.90% 2.59%
Net Nonoperating Expense Percent (NNEP)		 -5.60% -6.36% -6.56% -8.12% -6.15% -6.62% -6.19% -1.47% -2.31% 2.22% 1.45%
Return On Investment Capital (ROIC_SIMPLE)		 - - - -7.88% - - - -1.90% -0.78% -0.34% 0.94%
Cost of Revenue to Revenue		 36.97% 35.30% 33.77% 33.44% 33.61% 32.13% 32.34% 30.60% 32.83% 32.10% 31.60%
SG&A Expenses to Revenue		 23.71% 24.45% 22.09% 19.81% 18.82% 19.09% 18.38% 16.79% 14.15% 16.24% 14.53%
R&D to Revenue		 31.57% 32.01% 31.16% 31.43% 28.53% 28.93% 27.45% 27.01% 27.45% 24.97% 24.48%
Operating Expenses to Revenue		 108.23% 107.75% 101.21% 97.69% 85.58% 84.73% 80.62% 76.34% 70.00% 69.18% 65.29%
Earnings before Interest and Taxes (EBIT)		 -38 -37 -32 -29 -19 -17 -14 -5.40 -2.95 -1.17 4.75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -31 -30 -24 -21 -13 -9.76 -5.52 1.60 4.10 6.54 12
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 6.40 6.89 2.85 5.64 4.63 5.70 4.15 6.25 5.20 5.38 4.23
Price to Tangible Book Value (P/TBV)		 9.34 11.18 6.71 14.49 11.95 14.94 10.74 15.31 11.69 11.31 8.23
Price to Revenue (P/Rev)		 5.60 5.33 2.23 3.98 3.13 3.67 2.61 3.94 3.38 3.57 2.93
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 12.17 11.82 3.80 7.65 5.83 7.42 5.18 8.06 6.76 7.18 5.64
Enterprise Value to Revenue (EV/Rev)		 5.15 4.98 1.97 3.77 2.96 3.50 2.45 3.78 3.20 3.38 2.72
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 225.64 51.13
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 1,433.55 76.19 48.99 29.00 29.34 20.51
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.05 0.06 0.05 0.05 0.07 0.06 0.08 0.06 0.05 0.04 0.03
Long-Term Debt to Equity		 0.03 0.03 0.03 0.02 0.03 0.03 0.04 0.03 0.02 0.02 0.01
Financial Leverage		 -0.61 -0.58 -0.50 -0.45 -0.39 -0.36 -0.29 -0.28 -0.26 -0.28 -0.28
Leverage Ratio		 1.26 1.29 1.32 1.37 1.41 1.41 1.45 1.47 1.44 1.40 1.39
Compound Leverage Factor		 1.24 1.26 1.30 1.42 1.39 1.41 1.44 1.46 1.56 0.67 1.50
Debt to Total Capital		 4.93% 5.78% 4.89% 4.36% 6.11% 5.44% 7.00% 5.76% 4.89% 3.77% 2.90%
Short-Term Debt to Total Capital		 2.52% 2.71% 2.43% 2.30% 2.88% 2.69% 3.24% 2.86% 2.81% 2.29% 1.88%
Long-Term Debt to Total Capital		 2.41% 3.07% 2.46% 2.05% 3.23% 2.75% 3.76% 2.90% 2.08% 1.48% 1.02%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 95.07% 94.22% 95.11% 95.64% 93.89% 94.56% 93.00% 94.24% 95.11% 96.23% 97.10%
Debt to EBITDA		 -0.10 -0.12 -0.12 -0.11 -0.19 -0.21 -0.39 -0.62 -1.51 1.74 0.39
Net Debt to EBITDA		 1.00 0.90 0.77 0.72 0.72 1.00 1.28 2.60 7.97 -12.87 -3.93
Long-Term Debt to EBITDA		 -0.05 -0.06 -0.06 -0.05 -0.10 -0.11 -0.21 -0.31 -0.64 0.68 0.14
Debt to NOPAT		 -0.12 -0.14 -0.13 -0.12 -0.20 -0.21 -0.34 -0.40 -0.49 -0.64 -1.57
Net Debt to NOPAT		 1.19 1.04 0.87 0.80 0.76 0.98 1.12 1.67 2.60 4.71 15.96
Long-Term Debt to NOPAT		 -0.06 -0.07 -0.07 -0.06 -0.11 -0.11 -0.18 -0.20 -0.21 -0.25 -0.55
Altman Z-Score		 9.71 9.19 2.39 5.32 4.11 5.91 3.48 6.45 6.00 7.38 6.78
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.89 2.58 2.02 1.78 1.76 1.77 1.74 1.78 1.95 2.12 2.44
Quick Ratio		 2.44 2.14 1.63 1.38 1.35 1.40 1.40 1.38 1.50 1.67 1.97
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -30 -42 -77 -77 -76 -62 -27 -27 -18 -28 -28
Operating Cash Flow to CapEx		 -224.69% -159.70% -118.81% -39.14% -13.24% 149.41% 138.33% 230.32% 200.89% 285.18% 232.03%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.74 0.83 0.88 0.96 1.03 1.11 1.08 1.11 1.13 1.17 1.16
Accounts Receivable Turnover		 6.07 6.33 6.64 6.13 6.27 6.77 6.29 6.06 6.15 6.51 5.80
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 18.47 0.00 0.00 17.66 20.70 19.06 20.57 19.68
Accounts Payable Turnover		 16.88 12.93 10.92 12.84 17.78 17.36 9.95 19.14 28.11 21.30 13.34
Days Sales Outstanding (DSO)		 60.12 57.64 54.98 59.55 58.21 53.91 58.04 60.20 59.37 56.05 62.91
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 21.62 28.23 33.42 28.43 20.52 21.02 36.70 19.07 12.98 17.14 27.37
Cash Conversion Cycle (CCC)		 38.49 29.41 21.56 31.12 37.69 32.88 21.34 41.13 46.38 38.92 35.54
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 128 135 175 175 190 184 192 197 206 211 224
Invested Capital Turnover		 2.40 2.53 2.29 2.42 2.36 2.45 2.21 2.26 2.20 2.27 2.23
Increase / (Decrease) in Invested Capital		 3.39 16 55 56 62 49 17 21 16 27 32
Enterprise Value (EV)		 1,552 1,590 664 1,342 1,106 1,365 994 1,586 1,391 1,518 1,260
Market Capitalization		 1,688 1,702 754 1,418 1,169 1,432 1,057 1,654 1,467 1,604 1,356
Book Value per Share		 $4.94 $4.60 $4.79 $4.52 $4.48 $4.38 $4.41 $4.56 $4.80 $5.01 $5.35
Tangible Book Value per Share		 $3.39 $2.84 $2.04 $1.76 $1.74 $1.67 $1.70 $1.86 $2.14 $2.38 $2.75
Total Capital		 277 262 278 263 269 266 274 281 297 310 330
Total Debt		 14 15 14 11 16 14 19 16 15 12 9.55
Total Long-Term Debt		 6.69 8.06 6.85 5.40 8.69 7.30 10 8.15 6.16 4.58 3.35
Net Debt		 -136 -113 -90 -76 -63 -67 -63 -68 -76 -87 -97
Capital Expenditures (CapEx)		 6.08 5.84 5.31 7.86 5.45 7.40 4.18 7.06 7.39 5.20 6.67
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 14 14 4.20 4.10 11 4.29 7.50 13 22 26 42
Debt-free Net Working Capital (DFNWC)		 164 141 108 92 90 86 89 97 113 125 148
Net Working Capital (NWC)		 157 134 101 86 83 79 80 89 105 118 142
Net Nonoperating Expense (NNE)		 11 11 9.51 9.94 6.13 5.96 4.71 1.06 1.61 -1.71 -1.16
Net Nonoperating Obligations (NNO)		 -136 -113 -90 -76 -63 -67 -63 -68 -76 -87 -97
Total Depreciation and Amortization (D&A)		 7.42 7.15 7.78 8.52 6.93 7.55 8.47 6.99 7.05 7.71 7.65
Debt-free, Cash-free Net Working Capital to Revenue		 4.77% 4.32% 1.24% 1.15% 2.90% 1.10% 1.85% 3.12% 5.10% 5.86% 9.06%
Debt-free Net Working Capital to Revenue		 54.46% 44.30% 31.84% 25.71% 24.18% 22.08% 22.03% 23.18% 26.01% 27.71% 32.02%
Net Working Capital to Revenue		 52.15% 42.07% 29.84% 24.01% 22.11% 20.24% 19.84% 21.26% 24.09% 26.13% 30.68%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.70) ($0.68) ($0.58) ($0.55) ($0.35) ($0.31) ($0.25) ($0.11) ($0.07) $0.01 $0.07
Adjusted Weighted Average Basic Shares Outstanding		 53.35M 53.79M 55.25M 54.56M 56.67M 57.50M 57.89M 57.59M 58.92M 59.59M 60.01M
Adjusted Diluted Earnings per Share		 ($0.70) ($0.68) ($0.58) ($0.55) ($0.35) ($0.31) ($0.25) ($0.11) ($0.07) $0.01 $0.07
Adjusted Weighted Average Diluted Shares Outstanding		 53.35M 53.79M 55.25M 54.56M 56.67M 57.50M 57.89M 57.59M 58.92M 61.69M 61.56M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 53.66M 55.21M 55.63M 56.39M 57.40M 57.77M 58.12M 58.77M 59.50M 59.91M 60.29M
Normalized Net Operating Profit after Tax (NOPAT)		 -27 -26 -22 -21 -14 -12 -9.69 -5.33 -2.30 -1.05 3.12
Normalized NOPAT Margin		 -31.64% -30.14% -24.48% -21.79% -13.43% -11.81% -9.07% -4.86% -1.98% -0.90% 2.59%
Pre Tax Income Margin		 -44.40% -42.08% -34.46% -32.03% -18.98% -16.90% -13.07% -4.90% -2.74% -0.48% 4.26%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Phreesia, Inc. (PHR) has shown an improving profitability and liquidity picture in 2026, after several years of growth investments. Below are the key four-year trends (2023–2026) drawn from the quarterly cash flow, income statement, and balance sheet data you provided.

  • Net income to common turned positive in Q3 2026: Consolidated net income of $4.27 million and basic/diluted EPS of $0.07, signaling a potential bottom-line inflection after multi-year losses.
  • Gross margin remains strong in Q3 2026: about 68% (Gross Profit $82.31M on Revenue $120.33M), indicating solid product margins despite higher operating costs.
  • Operating cash flow improving in 2026: Net cash from continuing operating activities around $14.8–$15.5 million per quarter in Q1–Q3 2026, pointing to healthier cash generation.
  • Liquidity strength: Cash & equivalents of about $106.4 million in Q3 2026, up from levels in prior years, providing a solid liquidity cushion.
  • Balanced balance sheet with modest leverage: Total assets near $423.5 million and total equity around $320 million; long-term debt remains minimal (roughly $3–6 million in recent quarters).
  • Revenue has trended upward over four years, rising from the mid-70s to roughly $120 million in 2026, though quarterly results remain somewhat volatile.
  • Operating expense mix remains elevated, with recurring investments in R&D around $29–30 million per quarter and substantial SG&A, suggesting ongoing growth initiatives rather than immediate profitability.
  • Financing activity fluctuates quarter-to-quarter, reflecting varied debt repayments and equity actions, contributing to cash flow variability.
  • Historically, net income remained negative through 2023–2025, with several quarters showing meaningful losses before the 2026 inflection, underscoring ongoing profitability challenges.
  • Cash flow from operating activities was negative in several 2024–2025 quarters, indicating working capital and operating pressures during that period, and financing cash flows were often negative due to debt repayments and other financing actions.
05/12/26 10:15 AM ETAI Generated. May Contain Errors.

Phreesia Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Phreesia's financial year ends in January. Their financial year 2025 ended on January 31, 2025.

Phreesia's net income appears to be on an upward trend, with a most recent value of -$58.53 million in 2025, rising from -$18.19 million in 2018. The previous period was -$136.89 million in 2024. Find out what analysts predict for Phreesia in the coming months.

Phreesia's total operating income in 2025 was -$58.10 million, based on the following breakdown:
  • Total Gross Profit: $284.88 million
  • Total Operating Expenses: $342.98 million

Over the last 7 years, Phreesia's total revenue changed from $79.83 million in 2018 to $419.81 million in 2025, a change of 425.9%.

Phreesia's total liabilities were at $123.61 million at the end of 2025, a 4.0% increase from 2024, and a 93.9% increase since 2019.

In the past 6 years, Phreesia's cash and equivalents has ranged from $1.54 million in 2019 to $313.81 million in 2022, and is currently $84.22 million as of their latest financial filing in 2025.

Over the last 7 years, Phreesia's book value per share changed from 0.00 in 2018 to 4.56 in 2025, a change of 455.6%.


Related Companies

Financial statements for NYSE:PHR last updated on 12/14/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
BSEM: From OTC to Nasdaq Contender!
BioStem Technologies (OTC: BSEM) has posted seven consecutive profitable quarters and just released audited fi...
Huge Alerts | Sponsoredtc pixel
Yale just did the math (you owe Washington $1,500)
The Yale Budget Lab calculated that current U.S. trade policy is costing the average American household betwee...
Priority Gold | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Is $24 trillion about to move?
Bloomberg reports that S-P Dow Jones Indices is considering rule changes that could fast-track SpaceX into the...
The Oxford Club | Sponsoredtc pixel
SpaceX Launches Strange 'Dark Energy' Across America
SpaceX is deploying a newly permitted energy technology - one that analyst Joel Litman calls 'Dark Energy' - t...
Altimetry | Sponsoredtc pixel
Read this or regret it forever
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel